233 related articles for article (PubMed ID: 1685707)
21. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.
Rudnick G; Wall SC
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1817-21. PubMed ID: 1347426
[TBL] [Abstract][Full Text] [Related]
22. Possible interaction between an MAOI and "ecstasy".
Kaskey GB
Am J Psychiatry; 1992 Mar; 149(3):411-2. PubMed ID: 1346952
[No Abstract] [Full Text] [Related]
23. Methylenedioxyamphetamine ('Ecstasy') associated keratopathy.
O'Neill D; Dart JK
Eye (Lond); 1993; 7 ( Pt 6)():805-6. PubMed ID: 7907032
[No Abstract] [Full Text] [Related]
24. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
Tucker G
Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473
[No Abstract] [Full Text] [Related]
25. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
26. Lack of neurotoxicity after intra-raphe micro-injections of MDMA ("ecstasy").
Paris JM; Cunningham KA
NIDA Res Monogr; 1990; 105():333-4. PubMed ID: 1715034
[No Abstract] [Full Text] [Related]
27. MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity.
Gibb JW; Johnson M; Hanson GR
NIDA Res Monogr; 1989; 95():511. PubMed ID: 2577049
[No Abstract] [Full Text] [Related]
28. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
Gibb JW; Stone DM; Stahl DC; Hanson GR
NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
[TBL] [Abstract][Full Text] [Related]
29. Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies.
De Souza EB; Battaglia G
NIDA Res Monogr; 1989; 94():196-222. PubMed ID: 2575225
[TBL] [Abstract][Full Text] [Related]
30. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)].
Verweij AM
Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250
[TBL] [Abstract][Full Text] [Related]
31. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
Hashimoto K; Maeda H; Goromaru T
Brain Res; 1992 Sep; 590(1-2):341-4. PubMed ID: 1384935
[TBL] [Abstract][Full Text] [Related]
32. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.
Peroutka SJ; Newman H; Harris H
Neuropsychopharmacology; 1988 Dec; 1(4):273-7. PubMed ID: 2908020
[TBL] [Abstract][Full Text] [Related]
33. Neurochemistry and neurotoxicity of substituted amphetamines.
Wagner J; Peroutka SJ
Neuropsychopharmacology; 1990 Jun; 3(3):219-20. PubMed ID: 1973040
[No Abstract] [Full Text] [Related]
34. Dantrolene and 'ecstasy' overdose.
Larner AJ
Anaesthesia; 1993 Feb; 48(2):179-80. PubMed ID: 8096369
[No Abstract] [Full Text] [Related]
35. Neurochemical basis of neurotoxicity.
Gibb JW; Johnson M; Hanson GR
Neurotoxicology; 1990; 11(2):317-21. PubMed ID: 1978271
[TBL] [Abstract][Full Text] [Related]
36. Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity.
Schmidt CJ; Kehne JH; Carr AA; Fadayel GM; Humphreys TM; Kettler HJ; McCloskey TC; Padich RA; Taylor VL; Sorensen SM
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():25-32. PubMed ID: 7911139
[No Abstract] [Full Text] [Related]
37. Ecstasy--a dangerous drug.
Teggin AF
S Afr Med J; 1992 Apr; 81(8):431-2. PubMed ID: 1348879
[No Abstract] [Full Text] [Related]
38. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.
Ricaurte GA; DeLanney LE; Irwin I; Langston JW
Brain Res; 1988 Apr; 446(1):165-8. PubMed ID: 2897228
[TBL] [Abstract][Full Text] [Related]
39. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
Ricaurte GA; Finnegan KT; Irwin I; Langston JW
Ann N Y Acad Sci; 1990; 600():699-708; discussion 708-10. PubMed ID: 1701292
[No Abstract] [Full Text] [Related]
40. 5-HT, MDMA (ecstasy), and nimodipine effects on 45Ca-uptake into rat brain synaptosomes.
Park WK; Azmitia EC
Ann N Y Acad Sci; 1991; 635():438-40. PubMed ID: 1683755
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
